Parma, 4 August 2020 – Today, a press conference was held in the Press Room of the Stadio Ennio Tardini, during which the renewal of the partnership between Parma Calcio 1913 and PharmaNutra S.p.A. was announced, with the collaboration centring on the pharmaceutical company’s Cetilar® brand. The two entities are therefore set to work side by side for the fourth consecutive year, building on what they’ve already achieved together thanks to their shared, deep-rooted values.

It’s a heartfelt and much-desired renewal that represents continuity, with both parties now aiming to achieve new goals together. It shouldn’t be taken for granted either, with it coming at a very difficult time as the world fights the COVID-19 pandemic. But when you share values and objectives, teamwork is a natural consequence, as is the continuation of a journey that started in 2017. Now, the aim is to enjoy a new and stimulating sports season.

Cetilar® will be present on Parma Calcio’s shirts for the fourth successive season. The brand, which is becoming increasingly well known, can also be found in other sporting disciplines, including motorsports, running, sailing and Paralympic sports. The renewal means that Cetilar® and PharmaNutra will accompany Parma Calcio 1913 against opposition sides out on the pitch during the 2020/21 campaign. But that’s not all: Cetilar® will also be present on the Club’s Erreà training kits, meaning the brand will be alongside the Crociati as they work at the Collecchio Sports Centre. Of course, the long-standing collaboration between the company founded by brothers Andrea and Roberto Lacorte in 2003 and the Club’s medical staff shouldn’t be forgotten about either.

“PharmaNutra and Cetilar®️ will be by our side next year too,” said Parma Calcio 1913 President Pietro Pizzarotti. “I must stress that this shouldn’t be taken for granted, quite the contrary in fact. It’s a strong indicator of our shared values and objectives, in addition to a common identity. At such a difficult time for the whole world, teamwork is vital. This is why we’re all the more delighted that Cetilar®️ will be with us on our journey for another season. We’ve always been on the same wavelength and are very much looking forward to continuing our work together. We hope that more joy awaits for both of us.”

“We’d like to congratulate the team and Club on their excellent season, and we’re delighted that we’ll be able to accompany Parma Calcio during their next Serie A campaign. It’s a decision that we took during lockdown with the aim of consolidating a relationship that, as has been proven before, goes far beyond a simple sponsorship agreement,” explained PharmaNutra Managing Director Carlo Volpi during the press conference.

“At such a delicate time, we’re convinced that a vigorous restart is required in all sectors, including in professional football, which is a key part of the country’s economic and social fabric and will play a key role in its recovery. The game is a real driving force for all sports, including at an amateur and youth level. Despite the fact they operate in different sectors, PharmaNutra and Parma Calcio are two examples of Italian excellence, and both share the same values and ambitions. Our company is making a further step forward in its development: we’ve been strengthening our presence aboard, launching new products and developing increasingly innovative technology. By the end of the year, we’ll go from being listed on AIM to being on the STAR segment of the Italian Stock Exchange, further confirmation of our company’s path of growth,” concluded Volpi.


PharmaNutra S.p.A

Founded and led by President Andrea Lacorte and by Vice President Roberto Lacorte, Pharma Nutra was born in 2003, developing a number of unique nutritional products and services, overseeing the production process from start to finish, from the raw materials right up until the finished product. The effectiveness of the products is demonstrated by a range of scientific evidence, including 112 publications with over 7,000 patients. The company distributes and sells products within Italy and abroad. In Italy, sales activities are carried out through a network of over 140 Medical Sales Representatives, exclusively marketing PharmaNutra products to pharmacies across the country. Sales abroad are guaranteed in over 50 countries, with 34 partners among the world’s leading pharmaceutical companies. PharmaNutra is a market leader in the production of iron-based nutritional supplements under the SiderAL® brand, where they boast important patents on Sucrosomial Technology®. Over the years, the company have developed a clear strategy for managing all the stages of production: raw materials, patents, branding and clinical evidence.